Targeted Oncology CDSS MolecularMatch offers a clinical decision support platform (MMPower) focused on precision oncology, presenting a direct opportunity to expand with oncology departments, cancer centers, and biopharma collaborators seeking advanced tumor profiling insights and trial matching capabilities.

Clinical Trials Expansion Customers include hospitals, cancer centers, and genetic labs; there is potential to upsell expanded trial matching, data sharing, and trial enrollment workflows to research groups facing patient accrual challenges and need for evidence-based trial matching.

SMB to Midmarket Upsell With a small team (2-10 employees) and revenue in the low millions, MolecularMatch can target mid-sized cancer centers and community hospitals looking for cost-effective, SaaS-based precision medicine tools, offering scalable packages and flexible pricing.

Expansion via Free Portal The 2020 free web portal for COVID-19 trials signals openness to broader access; leverage this to propose integrated, payer-friendly access to diverse clinical trials and patient-centric search experiences within existing platforms.

Technology Partnerships Tech stack and cloud features indicate capability to integrate with health information systems, genetic labs, and informatics platforms; pursue partnerships for data interoperability, enhanced reporting, and co-marketed solutions with compatible vendors.